Alpha9 Theranostics Inc.
595 Burrard Street
Phone: (778) 231-2500
Member Sector: Medical Technology
Alpha 9 Theranostics is a clinical-stage biopharmaceutical company founded in 2019 by renowned scientists based at BC Cancer and the University of British Columbia.
The Company is using its world-class know-how in molecular design and targeting of radiotherapeutics to advance a portfolio of breakthrough technologies focused on the precision targeting of metastatic cancer. These technologies promise to potentially revolutionize the way in which metastatic cancer is both diagnosed and treated.
Alpha9 is developing a breakthrough that will significantly enhance PET imaging along with the identification and development of a unique new Prostate Cancer therapeutic that appears to have significant safety benefits over 1st generation products. With products that can both image and treat metastatic cancer, Alpha9 is really moving toward “Seeing A Cure”.